Morgan Stanley Ac Immune Sa Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Ac Immune Sa stock. As of the latest transaction made, Morgan Stanley holds 72,895 shares of ACIU stock, worth $212,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,895

Previous 72,004 1.24%

Holding current value

$212,853

Previous $134,000 9.7%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.48 - $2.2 $1,318 - $1,960	891 Added 1.24%	72,895 $147,000
Q1 2025 May 15, 2025	SELL	$1.87 - $2.98 $176,810 - $281,761	-94,551 Reduced 56.77%	72,004 $134,000
Q4 2024 Feb 14, 2025	BUY	$2.67 - $3.75 $271,309 - $381,052	101,614 Added 156.47%	166,555 $449,000
Q3 2024 May 14, 2025	SELL	$2.99 - $4.2 $41,040 - $57,649	-13,726 Reduced 17.45%	64,941 $245,000
Q3 2024 Nov 14, 2024	SELL	$2.99 - $4.2 $41,040 - $57,649	-13,726 Reduced 17.45%	64,941 $245,000
Q2 2024 May 14, 2025	SELL	$2.29 - $4.87 $201,263 - $428,014	-87,888 Reduced 52.77%	78,667 $313,000
Q2 2024 Oct 17, 2024	SELL	$2.29 - $4.87 $2.99 Million - $6.36 Million	-1,305,187 Reduced 94.32%	78,667 $313,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.87 $2.99 Million - $6.36 Million	-1,305,187 Reduced 94.32%	78,667 $313,000
Q1 2024 Oct 17, 2024	BUY	$2.66 - $4.87 $3.47 Million - $6.36 Million	1,305,187 Added 1659.13%	1,383,854 $4.1 Million
Q1 2024 Aug 16, 2024	SELL	$2.66 - $4.87 $993,206 - $1.82 Million	-373,386 Reduced 21.25%	1,383,854 $4.1 Million
Q1 2024 May 15, 2024	SELL	$2.66 - $4.87 $993,206 - $1.82 Million	-373,386 Reduced 21.25%	1,383,854 $4.1 Million
Q4 2023 Aug 16, 2024	BUY	$2.46 - $5.0 $4.13 Million - $8.39 Million	1,678,573 Added 2133.77%	1,757,240 $8.79 Million
Q4 2023 Feb 13, 2024	BUY	$2.46 - $5.0 $38,284 - $77,815	15,563 Added 0.89%	1,757,240 $8.79 Million
Q3 2023 Nov 15, 2023	SELL	$2.77 - $3.38 $45,328 - $55,310	-16,364 Reduced 0.93%	1,741,677 $4.96 Million
Q2 2023 Aug 14, 2023	SELL	$1.85 - $3.4 $356,274 - $654,775	-192,581 Reduced 9.87%	1,758,041 $5.2 Million
Q4 2022 Feb 14, 2023	SELL	$1.72 - $3.12 $45,975 - $83,397	-26,730 Reduced 1.35%	1,950,622 $3.98 Million
Q3 2022 Nov 14, 2022	BUY	$2.4 - $3.64 $19,603 - $29,731	8,168 Added 0.41%	1,977,352 $6.25 Million
Q2 2022 Oct 27, 2022	SELL	$2.35 - $4.47 $82,926 - $157,737	-35,288 Reduced 1.76%	1,969,184 $7.11 Million
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $82,926 - $157,737	-35,288 Reduced 1.76%	1,969,184 $7.11 Million
Q1 2022 Oct 27, 2022	BUY	$3.5 - $5.16 $123,508 - $182,086	35,288 Added 1.79%	2,004,472 $8.02 Million
Q1 2022 May 13, 2022	SELL	$3.5 - $5.16 $836,472 - $1.23 Million	-238,992 Reduced 10.65%	2,004,472 $8.02 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $8.15 Million - $12.8 Million	1,687,761 Added 303.72%	2,243,464 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $3.45 Million - $4.63 Million	555,703 New	555,703 $3.73 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.9M

Call Options Held

Put Options Held

28.5K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $244M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account